|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!
Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.
OAs part of APhA's longstanding and ongoing commitment to helping its members ensure optimal and safe patient use of prescription medications, nonprescription products, and dietary supplements, APhA convened national pharmacy and medicine leaders and other stakeholders on March 26.
Click here for more information
Click Here to visit the Population Health Management Institute
With merging of insurers, questions for patients about costs and innovation
The New York Times
The nation’s five largest health insurance companies are circling one another like hungry lions closing in on prey. Aetna said it would acquire its smaller rival Humana to create a company with combined revenues of $115 billion this year. Anthem is stalking Cigna. UnitedHealth Group, now the largest of the five, is looking at its options. At the end of the maneuverings, three national behemoths are likely to emerge.
Health insurance premiums are rising faster than income
In every budget, we can control what we pay for some items while others are out of our control. Health insurance premiums are one of those items over which the consumer has little or no control. In this article, we’ll look at the rise in health insurance premiums from 2005 to 2014 and compare it to personal income.
Science shows health coverage works
Legal and political experts will be discussing the ramifications of the Supreme Court's historic ruling in King v. Burwell for months to come, but the case's impact is purely personal for 6.4 million people in 34 states.
Many of these individuals are currently battling chronic disease and will continue to receive the tax credits that help them afford the health plan they bought in the federal marketplace.
ACCOUNTABLE CARE ORGANIZATIONS
Population health cuts Anthem ACO costs by nearly $8M
Health IT Outcomes
Anthem Blue Cross of California announced it has saved almost $8 million in one year by focusing on preventive care. Anthem said the savings came under its Enhanced Personal Health Care Program, which “targets PPO members with two or more chronic conditions to improve their overall health through enhanced care coordination,” by improving total population health.
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.
Request more information or schedule a personal introduction.
CMS investment model changes boost rural ACOs
Health Data Management
The Centers for Medicare and Medicaid Services has announced two new changes to the design of the ACO Investment Model.
As of June 25, the eligibility criteria for the model have changed to include Medicare Shared Savings Program ACOs that started on January 1, 2015 and to provide greater opportunities for rural ACOs to participate.
FDA: NEW TREATMENTS & TECHNOLOGY
FDA clears Vertex's new treatment for cystic fibrosis
The Boston Globe
Vertex Pharmaceuticals Inc. won U.S. regulatory approval for a medicine that eventually could treat roughly half of the estimated 30,000 Americans who suffer from cystic fibrosis, the life-threatening lung disease.
Pricing the two-drug therapy called Orkambi at $259,000 per patient annually, the company said it plans to begin shipping the treatment to specialty pharmacies within days.
FDA orders halt to unapproved prescription ear drops
The U.S. Food and Drug Administration has demanded a halt to the manufacture and distribution of unapproved prescription ear drop products labeled to relieve ear pain, infection and inflammation.
The products, which contain active ingredients such as benzocaine and hydrocortisone, have not been evaluated by the FDA for safety, effectiveness or quality.
FDA moves to add warnings, child-proof packaging for liquid nicotine
The Food and Drug Administration is taking steps to add exposure warning labels and child-resistant packaging to liquid nicotine.
The agency posted a 15-page "notice of proposed rulemaking" on its website, requesting "comments, data, research results or other information that may inform regulatory actions FDA might take" regarding warnings and packaging for liquid nicotine and other tobacco products.
Click Here to visit the Genomics, Biotech & Emerging Medical Technology Institute
Why the BRCA gene resists cancer treatment
Yale University researchers have discovered why a key molecular assistant is crucial to the function of the BRCA2 gene, which in some mutant forms can lead to ovarian and breast cancer in as many as 6 in 10 women.
The findings suggest how biochemists might be able to decrease drug resistance to existing therapies that target this form of cancer, the authors report in Molecular Cell.
Don't get your kids' genes sequenced just to keep up
You can now order genetic tests off the Internet and get your child's genome sequenced for less than the cost of a new car. The question is, should you?
Almost certainly not, according to the American Society for Human Genetics, which released a position paper Thursday intended to give parents some help navigating the dizzying world of genetic tests.
Ranked #1 in the Nation for Quality of Care.
Our Meaningful Use certified software is designed by medical providers, making SOAPware the preferred EHR for medical professionals!
To find out how to feature your company in the NAMCP eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
Editing stem cell genes will 'revolutionize' biomedical research
Applying a dramatically improved method for "editing" genes to human stem cells, University of Wisconsin-Madison professor of neuroscience Su-Chun Zhang has shown a new way to silence genes in stem cells and their progeny at any stage of development. The advance has advantages in speed and efficiency, says Zhang, and is already being used for basic biological studies.
Click Here to visit the Center for Preventive Health and Lifestyle Medicine
Is the FDA's trans fat ban really the answer to our obesity epidemic?
By Natalie Rodriguez
The time has finally come for Americans to wave goodbye to their toxic friend trans fat — a veteran contributor to heart disease in the United States. Trans fat extends the shelf life of our favorite processed foods, along with assisting in taste and texture. In 2013, the Food and Drug Administration issued a preliminary finding indicating that partially hydrogenated oils were not "generally recognized as safe," and recently finalized the determination.
Safer, with more benefits: Parents' vaccine views shifting
Over the same time period that multiple outbreaks of measles and whooping cough made headlines around the country, parents' views on vaccines became more favorable, according to a new nationally-representative poll. The University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health asked parents in May how their views on vaccinations changed between 2014 and 2015 — during which two dozen measles outbreaks were reported in the U.S., including a multi-state outbreak traced to Disneyland.
Click Here to visit the Oncology Institute
Mammograms find tiny tumors but are they deadly?
A new study adds to the confusing questions about mammograms and how many lives they save.
It found that while mammograms do indeed find breast tumors when they are very small and presumably the easiest to treat, widespread breast cancer screening doesn't necessarily lower the overall death rate from breast cancer or even cut back on the number of biggest breast tumors found later.
A perfect blood test for pancreatic cancer?
It’s not often that Nature publishes on a new way of detecting cancer. Recently the journal reported that bits of cancerous cells — tiny blebs containing protein, RNA and DNA — can be measured in blood samples from patients with pancreatic cancer. These particles, exosomes, might serve as tumor indicators, or biomarkers.
Click Here to visit the Behavioral Health Institute
Treat 'whole person' by bringing behavioral health into primary care
Reuters via Medical Daily
In a new position paper, the American College of Physicians lays out six strategies for bringing mental health and substance abuse care into primary care to better treat each patient as “a whole person.”
Mental and behavioral health issues like inappropriate eating behaviors, sedentary lifestyle and patterns of social isolation, are common, and have been linked to increased physical illness, higher mortality rates, poorer treatment outcomes and higher healthcare costs, the ACP committee writes in the Annals of Internal Medicine.
The strange link between junk food and depression
Of our many modern diseases, one of the biggest burdens on society is an unexpected one: depression, according to the World Health Organization. And what we eat may be contributing, finds a new study published in the American Journal of Clinical Nutrition.
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063